Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cochran's Q Test01:17

Cochran's Q Test

Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square distribution,...
Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers.

Health affairs scholar·2025
Same author

Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval.

The Milbank quarterly·2023
Same author

Turning CMS into a Health Technology Assessment Organization.

The New England journal of medicine·2023
Same author

Proposed framework for patient-centered outcomes-based measures in alternative payment models.

The American journal of managed care·2021
Same author

Introduction.

The Journal of rheumatology·2019
Same author

The increasing complexity of the core outcomes landscape.

Journal of clinical epidemiology·2019
Same journal

Covid-19 vaccine study pulled by US CDC is finally published.

BMJ (Clinical research ed.)·2026
Same journal

The doctor will post you now.

BMJ (Clinical research ed.)·2026
Same journal

RSV vaccination programme expanded to thousands more vulnerable people.

BMJ (Clinical research ed.)·2026
Same journal

Adult gender dysphoria services after the Levy review.

BMJ (Clinical research ed.)·2026
Same journal

Blood pressure and cholesterol levels between normal weight and obese adults have narrowed thanks to medications, study says.

BMJ (Clinical research ed.)·2026
Same journal

Amos review fallout: national maternity adviser demands answers over removal of "normal birth" harms.

BMJ (Clinical research ed.)·2026
See all related articles

Related Experiment Video

Updated: May 19, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

Improving comparative effectiveness research

Sean R Tunis

    BMJ (Clinical Research Ed.)
    |August 4, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
    06:05

    The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

    Published on: February 19, 2021

    Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
    08:27

    Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

    Published on: September 27, 2019

    Related Experiment Videos

    Last Updated: May 19, 2026

    A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
    14:43

    A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

    Published on: January 12, 2018

    The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
    06:05

    The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time

    Published on: February 19, 2021

    Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
    08:27

    Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

    Published on: September 27, 2019